Article

Nerve Growth Factor Eye Drops for Optic Pathway Gliomas: Four-Year Follow-Up Findings in Children After a Single Treatment Course

2026-07-29

Abstract excerpt

<title>Abstract</title> <p>Purpose. A previous double-blind, randomized, placebo-controlled, phase II clinical trial reported beneficial effects of a short-term treatment (10 days) with murine nerve growth factor (mNGF) eye drops on visual function in children with optic pathway gliomas (OPG). The present study aimed to evaluate long-term changes in clinical and neuroradiological parameters in the cohort of OPG...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4acbd051-c7c0-5220-8c84-98b6c94e9826
DOI: 10.21203/rs.3.rs-10466798/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Nerve Growth Factor Eye Drops for Optic Pathway Gliomas: Four-Year Follow-Up Findings in Children After a Single Treatment CourseDOI 10.21203/rs.3.rs-10466798/v1Read

The Temporal Dynamics of Pathological Profile and Functional Impairment in Neuromyelitis Optica Spectrum Disorders associated Optic NeuritisSemantic proximity Read

Visual acuity of children treated with chemotherapy for optic pathway gliomas.Semantic proximity Read

Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.Semantic proximity Read

Functional and Structural Outcomes in Paediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Prospective StudySemantic proximity Read

Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?Semantic proximity Read

Protocol to test the efficacy and safety of frequent applications of skin electrical stimulation for Leber hereditary optic neuropathy: a single-arm, open-label, non-randomised prospective study.Semantic proximity Read

Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study.Semantic proximity Read

Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases.Semantic proximity Read

Levetiracetam-Induced Visual Impairment in a Pediatric Patient with CNS embryonal tumor: A Case ReportSemantic proximity Read

12-month outcomes after voretigene neparvovec gene therapy in paediatric patients with RPE65 -mediated inherited retinal dystrophySemantic proximity Read

Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center studySemantic proximity Read

Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.Semantic proximity Read